We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.5B
AUM Growth
+$1.41B
Cap. Flow
+$347M
Cap. Flow %
3.32%
Top 10 Hldgs %
19.17%
Holding
2,407
New
262
Increased
1,175
Reduced
775
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 6.32%
2 Financials 4.92%
3 Healthcare 4.22%
4 Consumer Discretionary 3.74%
5 Industrials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
2251
Trekor Metals
TGB
$3.23B
$18K ﹤0.01%
31,350
IDXG
2252
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$18K ﹤0.01%
2,260
NAVB
2253
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$16K ﹤0.01%
5,905
-32
-0.5% -$94
GENE
2254
DELISTED
Genetic Technologies Ltd.
GENE
$15K ﹤0.01%
850
OBE
2255
Obsidian Energy
OBE
$710M
$13K ﹤0.01%
6,876
+79
+1% +$210
UPL
2256
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$13K ﹤0.01%
21,512
KONA
2257
DELISTED
Kona Grill, Inc.
KONA
$12K ﹤0.01%
13,500
PTN
2258
Palatin Technologies
PTN
$13.2M
$11K ﹤0.01%
9
VIVS
2259
VivoSim Labs
VIVS
$1.23M
$11K ﹤0.01%
45
-53
-54% -$13.3K
NVAX icon
2260
Novavax
NVAX
$1.31B
$10K ﹤0.01%
878
-185
-17% -$5.84K
SDLP
2261
DELISTED
SEADRILL PARTNERS LLC
SDLP
$9K ﹤0.01%
1,065
WFT
2262
DELISTED
Weatherford International plc
WFT
$8K ﹤0.01%
11,826
-917
-7% -$635
CNSY
2263
Cerenome, Inc. Common Stock
CNSY
$26.4M
$5K ﹤0.01%
+1
New +$5.28K
LGCY
2264
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$5K ﹤0.01%
+10,910
New +$14.7K
AREX
2265
DELISTED
Approach Resources Inc.
AREX
$4K ﹤0.01%
11,000
ABEV icon
2266
Ambev
ABEV
$43.9B
-10,372
Closed -$41K
ADMA icon
2267
ADMA Biologics
ADMA
$2.22B
-10,000
Closed -$24K
ADME icon
2268
Aptus Behavioral Momentum ETF
ADME
$306M
-12,846
Closed -$363K
ADUS icon
2269
Addus HomeCare
ADUS
$2.18B
-12,414
Closed -$843K
AKR icon
2270
Acadia Realty Trust
AKR
$2.83B
-16,371
Closed -$389K
AMED
2271
DELISTED
Amedisys
AMED
-8,712
Closed -$1.02M
AMX icon
2272
America Movil
AMX
$70.3B
-11,097
Closed -$158K
APO icon
2273
Apollo Global Management
APO
$80.8B
-9,855
Closed -$242K
APYX icon
2274
Apyx Medical
APYX
$127M
-22,995
Closed -$149K
ATHM icon
2275
Autohome
ATHM
$2.65B
-7,967
Closed -$623K

Similar funds

Cambridge Investment Research Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Cambridge Investment Research Advisors held 2,407 positions worth $10.5B, up 16% from $9.04B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors deployed $347M of net new capital in Q1 2019, opening 262 new positions and adding to 1,175 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 149,602 shares worth $6.22M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was TotalEnergies, an estimated $97.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2019 buy was Invesco S&P 500 High Beta ETF: 149,602 shares worth $6.22M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q1 2019, an estimated $34.3M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $97.5M.
  • Cambridge Investment Research Advisors fully exited ProShares Short S&P500 in Q1 2019, selling an estimated $7.97M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.5B portfolio in Q1 2019.
  • Cambridge Investment Research Advisors opened 262 new positions and closed 133 in Q1 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 16% quarter-over-quarter to $10.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.